Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
DAPI (hydrochloride): Innovations in DNA Quantitation and Im
2026-05-31
Explore the advanced scientific uses of DAPI (hydrochloride) as a DNA-specific probe in cell analysis and immunomodulation research. This article reveals mechanistic insights and strategic assay considerations that set it apart from standard guidance.
-
Amiloride (MK-870): Redefining Ion Channel Modulation in Mod
2026-05-30
Explore how Amiloride (MK-870) advances sodium channel research through precise ENaC and uPAR inhibition. This in-depth article uncovers mechanistic insights, protocol strategies, and future outlooks for translational research.
-
Reserpine (N1867): Technical Guidance for Lab-Based Research
2026-05-29
Reserpine (SKU N1867) is a high-purity, well-characterized compound for controlled neurotransmitter depletion, antihypertensive mechanism studies, and neuropharmacology workflows. It addresses reproducibility and consistency needs in laboratory research, but is not suitable for diagnostic or clinical use, nor for long-term solution storage.
-
Nocodazole: Applied Protocols for Microtubule Dynamics Resea
2026-05-29
Nocodazole stands out as a gold-standard microtubule polymerization inhibitor, enabling reproducible cell cycle regulation assays and advanced cancer research. This article unpacks actionable workflows, troubleshooting strategies, and translational insights, drawing from both peer-reviewed studies and APExBIO’s validated protocols.
-
Bispecific Antibody Strategies for Orthopoxvirus Neutralizat
2026-05-28
This study provides a detailed functional and epitope map of monoclonal antibodies targeting the major mpox virus proteins M1R and B6R, and introduces bispecific antibody formats with enhanced protective efficacy against orthopoxvirus infection. These findings offer a blueprint for next-generation antibody therapeutics and inform the rational design of broad-spectrum antiviral interventions.
-
BRD4770: G9a Histone Methyltransferase Inhibitor in Cancer R
2026-05-28
BRD4770 from APExBIO is a robust chemical tool for dissecting epigenetic regulation and suppressing tumorigenic pathways in cancer biology. Its unique inhibition of G9a-mediated H3K9 methylation enables targeted workflows in senescence and proliferation assays, with proven utility in challenging models like PANC-1 and advanced breast cancer subtypes.
-
Recombinant Human IL-15: Precision Tools for Immune Circuitr
2026-05-27
Explore how Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) enables nuanced dissection of immune cell dynamics and neuroimmune interactions. This article delves into experimental design, protocol optimization, and translational insights beyond standard proliferation assays.
-
Crizotinib Hydrochloride in Assembloid Models: ALK Kinase In
2026-05-27
Crizotinib hydrochloride empowers advanced cancer research by enabling precise ALK and c-Met kinase inhibition in physiologically relevant assembloid systems. This article unpacks stepwise protocols, real-world troubleshooting, and translational insights—bridging bench workflows with the next generation of gastric cancer modeling.
-
Cell Tumbling Drives Stem Cell Differentiation via Nuclear M
2026-05-26
This study introduces the concept of 'cell tumbling'—a rapid, three-dimensional movement in hydrogels—as a key driver of mesenchymal stem cell differentiation through nuclear mechanotransduction. The findings clarify how fast mechanical interactions with the matrix influence chromatin accessibility and lineage commitment, offering new experimental angles for tissue engineering and mechanobiology research.
-
Cyclic di-GMP (SKU B7839): Reliable Solutions for Lab Biofil
2026-05-26
This article delivers scenario-driven, evidence-backed guidance for biomedical researchers and lab professionals using Cyclic di-GMP (SKU B7839) in biofilm and immune modulation studies. Drawing on current literature and the APExBIO product dossier, it addresses practical challenges in protocol optimization, data interpretation, and product selection—supporting reproducibility and translational impact.
-
Gramine in Triple-Negative Breast Cancer: Molecular Mechanis
2026-05-25
Explore how Gramine, a potent ferroptosis inducer, advances triple-negative breast cancer research by modulating CUL3-mediated ubiquitination of MTDH. This article delivers in-depth mechanistic insights, practical assay recommendations, and a unique translational perspective for cancer biology investigators.
-
nor-Binaltorphimine Dihydrochloride: Circuit-Specific Insigh
2026-05-25
Explore the advanced application of nor-Binaltorphimine dihydrochloride as a selective κ-opioid receptor antagonist. This article reveals how circuit-level discoveries are shaping pain modulation research and practical assay design.
-
Sulfaphenazole: Selective CYP2C9 Inhibitor for Vascular and
2026-05-24
Sulfaphenazole is a highly selective CYP2C9 inhibitor with proven efficacy in vascular endothelial function research and antibacterial studies. Its unique ability to inhibit cytochrome P450 2C9 and 2C6, while exhibiting low cytotoxicity, enables broad translational applications. APExBIO’s Sulfaphenazole (C4131) is widely utilized in drug metabolism modulation and wound healing models.
-
Adefovir (GS-0393): Advanced Antiviral Mechanisms and Transl
2026-05-23
Explore how Adefovir (GS-0393) serves as a precision HBV antiviral agent, with a deep dive into its DNA polymerase inhibition pathway, renal transporter profiling, and practical considerations for hepatitis B virus research. This article offers new translational perspectives and protocol clarity beyond standard reviews.
-
SOX9 and MAML2 Mediate β-Catenin Turnover Independently of G
2026-05-22
Sinha et al. reveal a novel pathway for repressing Wnt/β-catenin signaling, showing that SOX9 induces MAML2 to promote β-catenin degradation independently of the canonical destruction complex and proteasome. This finding refines our understanding of signaling regulation in development and stem cell biology, with implications for stem cell fate and disease modeling.